KUALA LUMPUR, Nov 3 (Bernama) -- Tessa Therapeutics Ltd, a clinical-stage biotechnology company with global headquarters in Singapore, has announced that its president and chief executive officer Thomas Willemsen as well as chief medical officer and chief scientific officer Dr Ivan D. Horak will attend the upcoming Stifel Healthcare Conference 2022 in New York.
At the conference on Nov 15-16, 2022, they, along with chief financial officer Wilson W. Cheung, will conduct one-on-one meetings with registered investors, the company said in a statement.
It added that they will showcase Tessa Therapeutics’ business and clinical development strategy, recent corporate achievements, and anticipated milestones.
Tessa Therapeutics, which operates a state-of-the-art, commercial cell therapy manufacturing facility in Singapore, is developing next-generation cell therapies for treating haematological cancers and solid tumours.
More details at www.tessacell.com.
-- BERNAMA
No comments:
Post a Comment